The dynamics of human cytomegalovirus replication in vivo

被引:195
作者
Emery, VC [1 ]
Cope, AV [1 ]
Bowen, EF [1 ]
Gor, D [1 ]
Griffiths, PD [1 ]
机构
[1] UCL, Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2QG, England
基金
英国惠康基金;
关键词
polymerase chain reaction; quantitation; ganciclovir; mutation; fitness;
D O I
10.1084/jem.190.2.177
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytomegalovirus (CMV) is generally described as a slowly replicating virus. During studies of immunocompromised patients, we observed rapid changes in the quantity of CMV DNA present in serial blood samples by quantitative-competitive polymerase chain reaction commensurate with a doubling time of <2 d. To further investigate the dynamics of replication in vivo, patients in three distinct situations were studied in detail: (a) those receiving intravenous ganciclovir; (b) those in whom ganciclovir-resistant strains appeared during long-term therapy; and (c) those in whom ganciclovir-resistant strains disappeared with alternative drug therapy. In all cases, it was possible to provide accurate estimates of the doubling time of CMV and its half-life of disappearance after antiviral chemotherapy. The results from all three approaches demonstrated that the doubling time/half-life of CMV in blood is similar to 1 d when frequent samples are collected. These results show that CMV DNA replication in vivo is a highly dynamic process. We conclude that the reputation of CMV as a slowly replicating virus based on the time taken to produce cytopathic effects in vitro is unwarranted. These findings have implications for the potency, dose, and duration of antiviral chemotherapy needed for the effective treatment of this important human pathogen.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 35 条
  • [1] Virus dynamics and drug therapy
    Bonhoeffer, S
    May, RM
    Shaw, GM
    Nowak, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) : 6971 - 6976
  • [2] Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631
  • [3] Human immunodeficiency virus drug therapy and virus load
    Bonhoeffer, S
    Coffin, JM
    Nowak, MA
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 3275 - 3278
  • [4] Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis
    Bowen, EF
    Emery, VC
    Wilson, P
    Johnson, MA
    Davey, CC
    Sabin, CA
    Farmer, D
    Griffiths, PD
    [J]. AIDS, 1998, 12 (06) : 605 - 611
  • [5] Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease
    Bowen, EF
    Sabin, CA
    Wilson, P
    Griffiths, PD
    Davey, CC
    Johnson, MA
    Emery, VC
    [J]. AIDS, 1997, 11 (07) : 889 - 893
  • [6] Bowen EF, 1996, AIDS, V10, P1515, DOI 10.1097/00002030-199611000-00009
  • [7] Bowen EF, 1997, J VIROL METHODS, V68, P225
  • [8] FREQUENCY OF UL97 PHOSPHOTRANSFERASE MUTATIONS RELATED TO GANCICLOVIR RESISTANCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES
    CHOU, SW
    GUENTZEL, S
    MICHELS, KR
    MINER, RC
    DREW, WL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) : 239 - 242
  • [9] REACTIVATION AND RECOMBINATION OF MULTIPLE CYTOMEGALO-VIRUS STRAINS FROM INDIVIDUAL ORGAN DONORS
    CHOU, SW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (01) : 11 - 15
  • [10] Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation
    Cope, AV
    Sabin, C
    Burroughs, A
    Rolles, K
    Griffiths, PD
    Emery, VC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) : 1484 - 1490